| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Apr―29 |
COVID-19: An Updated View as of 2025 |
Stefano Fiorucci, Ginevra Urbani |
| 2 |
[GO] |
2024―Jul―29 |
A Comparative Study of Dexamethasone and Methylprednisolone in COVID-19 Patients: Clinical Outcomes and Inflammatory Markers |
Alireza Ziaei Moghaddam, Mostafa Soleimani, Behnam Imani, Sepide Hejazi, Mohammadhossein Taherynejad, Mona Kabiri, et al. (+2) Maryam Emadzadeh, Sahar Ravanshad |
| 3 |
[GO] |
2023―Okt―23 |
Olfactory Dysfunction in Healthcare Workers with COVID-19: Prevalence
and Associated Factors |
Imene Kacem, Mohamed Kahloul, Amel Ghenim, Mohamed Ajmi, Asma Chouchane, Asma Aloui, et al. (+6) Wael Khalefa, Olfa El Maalel, Maher Maoua, Walid Naija, Nejib Mrizak, Kalboussi Houda |
| 4 |
[GO] |
2023―Okt―15 |
The Prognostic Role of Corticosteroid Administration in Hospitalized
Patients with Severe COVID-19: A Cross-sectional Study |
Mohammad Ali Yaghoubi, Hassan Mehrad-Majd, Ali Moradi, Mohammad Moein Vakilzadeh, Zahra Mazloum Khorasani, Mahmoud Ghavi, Amirhossein Sahebkar |
| 5 |
[GO] |
2023―Jun―02 |
Bile Acids and SARS-CoV-2: Ursodeoxycholic Acid as a Potential Treatment of
COVID-19 |
Stefano Fiorucci, Ginevra Urbani, Eleonora Distrutti |
| 6 |
[GO] |
2022―Dez―07 |
COVID-19 associated Pancytopenia (CAP): A Clinical Impact |
Anju Dinkar, Jitendra Singh, Nilesh Kumar, Kailash Kumar |
| 7 |
[GO] |
2022―Nov―28 |
Role of mRAGEs and ACE2 in SARS-CoV-2-Related Inflammation |
Ginevra Urbani, Stefano Fiorucci |
| 8 |
[GO] |
2022―Mrz―21 |
Increased ACE2, sRAGE, and immune activation, but lowered calcium and magnesium in COVID-19. |
Hussein Kadhem Al-Hakeim, Hawraa Kadhem Al-Jassas, Gerwyn Morris, Michael Maes |
|
